Liyao Liu Selected Research

2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))

1/2018

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liyao Liu Research Topics

Disease

2	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2023 - 01/2023
2	Hemorrhage 01/2022 - 01/2018
2	Thrombosis (Thrombus) 01/2022 - 01/2018
1	Eczema 08/2023
1	Skin Diseases (Skin Disease) 08/2023
1	Infectious Skin Diseases 08/2023
1	Diabetic Foot 08/2023
1	Pressure Ulcer (Bedsore) 08/2023
1	Dermatitis 08/2023
1	Sepsis (Septicemia) 01/2023
1	Hypertension (High Blood Pressure) 10/2021
1	Myocardial Infarction 01/2018
1	Atrial Fibrillation 01/2018
1	Ischemic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2023
1	OzoneIBA 08/2023
1	CreatinineIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	ProcalcitoninIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	bivalirudin (Angiomax)FDA Link 01/2022
1	IronIBA 10/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018

Therapy/Procedure

2	Therapeutics 08/2023 - 01/2018
1	Stents 01/2018